MXPA04008536A - Forma de dosificacion de liberacion controlada. - Google Patents
Forma de dosificacion de liberacion controlada.Info
- Publication number
- MXPA04008536A MXPA04008536A MXPA04008536A MXPA04008536A MXPA04008536A MX PA04008536 A MXPA04008536 A MX PA04008536A MX PA04008536 A MXPA04008536 A MX PA04008536A MX PA04008536 A MXPA04008536 A MX PA04008536A MX PA04008536 A MXPA04008536 A MX PA04008536A
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- core tablet
- pharmaceutical
- pharmaceutical dosage
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36182102P | 2002-03-04 | 2002-03-04 | |
US29161902A | 2002-11-12 | 2002-11-12 | |
PCT/US2003/006591 WO2003075893A1 (fr) | 2002-03-04 | 2003-03-03 | Formes posologiques a liberation controlee |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04008536A true MXPA04008536A (es) | 2005-09-08 |
Family
ID=27807664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04008536A MXPA04008536A (es) | 2002-03-04 | 2003-03-03 | Forma de dosificacion de liberacion controlada. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1492508A4 (fr) |
JP (1) | JP2005524670A (fr) |
KR (1) | KR20100049695A (fr) |
CN (1) | CN1649569B (fr) |
AU (2) | AU2003217909C1 (fr) |
BR (1) | BR0308305A (fr) |
CA (1) | CA2477701A1 (fr) |
EA (1) | EA005866B1 (fr) |
IL (1) | IL163887A0 (fr) |
MX (1) | MXPA04008536A (fr) |
NO (1) | NO20044188L (fr) |
NZ (1) | NZ535083A (fr) |
WO (1) | WO2003075893A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
RU2005104827A (ru) * | 2002-07-19 | 2006-07-27 | Рэнбакси Лабораториз Лимитед (In) | Таблетки суматриптана с замаскированным вкусом и способы их получения |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
CA2505861A1 (fr) * | 2002-11-12 | 2004-05-27 | Teva Pharmaceutical Industries Ltd. | Compositions pharmaceutiques et formes posologiques pour administration par voie buccale et sublinguale de tizanidine et methodes d'administration par voie buccale ou sublinguale |
WO2005046978A1 (fr) * | 2003-11-14 | 2005-05-26 | Sanwa Kagaku Kenkyusho Co., Ltd. | Procede pour la fabrication d'un moulage a noyau |
GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
CN1921866A (zh) * | 2004-02-19 | 2007-02-28 | 特瓦制药工业有限公司 | 使用雷洛昔芬和阿伦膦酸盐的改善的联合治疗 |
KR100701409B1 (ko) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | 호박산 수마트립탄을 함유하는 약제학적 조성물 |
WO2010019915A1 (fr) | 2008-08-15 | 2010-02-18 | Depomed Inc. | Compositions pharmaceutiques de rétention gastrique destinées au traitement et à la prévention de troubles du snc |
CN110368371A (zh) * | 2014-04-08 | 2019-10-25 | 越洋医药开发(广州)有限公司 | 一种新型控释片 |
JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
CN110604724A (zh) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | 一种肠溶美沙拉秦缓释片剂及其制备方法 |
WO2024081456A1 (fr) * | 2022-10-13 | 2024-04-18 | Clarke Mosquito Control Products, Inc. | Compositions de comprimés insecticides |
JP2024083720A (ja) * | 2022-12-12 | 2024-06-24 | パナソニックIpマネジメント株式会社 | 水処理用徐放性固形薬剤 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
JPS61243016A (ja) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | 柱状の有効成分含有部分をもつ錠剤 |
GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
JPS6253918A (ja) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | 柱状の有効成分含有部分を埋没させた錠剤 |
DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
CA2184316A1 (fr) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Systeme d'administration buccale pour agents therapeutiques |
ES2173372T3 (es) * | 1997-12-19 | 2002-10-16 | Merck Patent Gmbh | Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias. |
PE20000012A1 (es) * | 1997-12-22 | 2000-01-18 | Schering Corp | Composicion para dispersion molecular con biodisponibilidad aumentada |
JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
AU2001271700A1 (en) * | 2000-06-28 | 2002-01-08 | Nitrosystems, Inc. | Controlled release arginine formulations |
EP1465606A4 (fr) * | 2001-12-24 | 2009-04-22 | Teva Pharma | Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique |
-
2003
- 2003-03-03 CN CN038101068A patent/CN1649569B/zh not_active Expired - Fee Related
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/fr active Application Filing
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 EP EP03713882A patent/EP1492508A4/fr not_active Withdrawn
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/ja active Pending
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/es active IP Right Grant
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 EA EA200401097A patent/EA005866B1/ru not_active IP Right Cessation
- 2003-03-03 CA CA002477701A patent/CA2477701A1/fr not_active Abandoned
- 2003-03-03 IL IL16388703A patent/IL163887A0/xx unknown
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/pt not_active IP Right Cessation
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/ko not_active Application Discontinuation
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/no not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1649569A (zh) | 2005-08-03 |
IL163887A0 (en) | 2005-12-18 |
EA005866B1 (ru) | 2005-06-30 |
AU2009200353A1 (en) | 2009-02-19 |
CA2477701A1 (fr) | 2003-09-18 |
EA200401097A1 (ru) | 2005-04-28 |
JP2005524670A (ja) | 2005-08-18 |
BR0308305A (pt) | 2004-12-28 |
NO20044188L (no) | 2004-12-03 |
EP1492508A4 (fr) | 2009-05-06 |
WO2003075893A1 (fr) | 2003-09-18 |
AU2003217909C1 (en) | 2009-06-11 |
CN1649569B (zh) | 2010-05-05 |
KR20100049695A (ko) | 2010-05-12 |
AU2003217909A1 (en) | 2003-09-22 |
EP1492508A1 (fr) | 2005-01-05 |
AU2003217909B2 (en) | 2008-10-30 |
NZ535083A (en) | 2007-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040052843A1 (en) | Controlled release dosage forms | |
JP4414228B2 (ja) | 活性成分の芯錠剤が粉末または顆粒状材料の圧縮環状体の鞘に収められた剤形とその製造方法および器具類 | |
AU2009200353A1 (en) | Controlled release dosage forms | |
AU2003207755B2 (en) | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs | |
KR20070036797A (ko) | 장용 코팅된 중심정을 갖는 제형 | |
JP2012503020A (ja) | 有機化合物のガレヌス製剤 | |
KR20050023235A (ko) | 방출 조절 투여 형태 | |
ZA200407023B (en) | Controlled release dosage forms | |
AU2002352613B2 (en) | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it | |
JP2008507587A (ja) | 腸溶性被覆されたコアー錠剤を有する投与形 | |
ZA200405012B (en) | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of power or granular material, and process and tooling for producing it. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |